A Phase 3 Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With Fibromyalgia
Clinical trial NCT04508621 · COMPLETED
Trial details
- NCT number
- NCT04508621
- Sponsor
- Tonix Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-22
- Primary completion
- 2021-11-01
- Enrollment
- 514
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.